Early control of bloodsugar key for gestationaldiabetes jamanetworkopen
care program, and closely self-monitoring blood glucose levels, which patients were asked to do 4 times a day.
The authors said it was significant that nearly 90% of the patients who participated in the telehealth support program significantly improved their blood glucose levels before delivering their babies. The study included 26,774 individuals enrolled in the gestational diabetes program at Kaiser Permanente in Northern California between January 2007 and December 2017. The researchers analyzed the data on glucose control levels between diagnosis and delivery and found that patients were clustered into 4 different trajectories. About 40% were"stably optimal," starting out with good control and maintaining it.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
'Bionic pancreas' could make life easier for people with type 1 diabetesA new technology dubbed the 'bionic pancreas' may beat standard treatment in helping people with type 1 diabetes control their blood sugar levels, a clinical trial has found.
Lire la suite »
Alpha cell TXNIP deletion improves diabetes-associated hyperglycemia and hyperglucagonemiaAbstract. Thioredoxin-interacting protein (Txnip) has emerged as a key factor in pancreatic beta cell biology and its upregulation by glucose and diabetes contr
Lire la suite »
Early pregnancy glycemia predicts postpartum diabetesResearchers determine which women with GDM are most likely to test positive for this condition postpartum in an effort to prevent persistent DM.
Lire la suite »
Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19 medrxivpreprint UniofOxford EdinburghUni OfficialUoM unisouthampton COVID19 coronavirus covid
Lire la suite »
Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samplesEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulating in the bloodstream—the so-called 'liquid biopsy'—has become a research focal point. But using this method to detect cancer at its early stages has been challenging due to low tumor concentrations in DNA blood fragments and the genetic diversity of cancer.
Lire la suite »
Blood test could identify long-COVID risk and allow early interventionIf the experimental test is validated by further research it may result in people at high risk of long-COVID being given anti-viral treatments in the hope of preventing debilitating symptoms.
Lire la suite »